Sumatriptan Tablet
Product Images NDC 76420-498

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 76420-498). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)

A line graph showing the estimated probability of response over time in minutes from the initial dose for Sumatriptan tablets at 25 mg, 50 mg, and 100 mg strengths compared to placebo. The graph shows increasing response probabilities over a 240-minute period, with higher doses generally showing greater response probabilities than placebo.*

FDA Label Image

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Poo (Sumatriptan Fig2)

A line chart depicting the estimated probability of headache remediation or rescue over time in hours from initial dose, comparing placebo and Sumatriptan tablets at doses of 25 mg, 50 mg, and 100 mg.*

FDA Label Image

Package Label-principal Display Panel (Sumatriptan Fig3)

Label for Sumatriptan Tablets USP 25 mg, oral tablet, relabeled by Enovachem Pharmaceuticals. The label indicates a quantity of 9 tablets and distribution by Aurobindo Pharma USA, Inc. It includes barcodes, NDC 76420-499-09, and storage instructions to keep out of reach of children and store at 20-25°C.*

FDA Label Image

Package Label-principal Display Panel (Sumatriptan Fig4)

Label for Sumatriptan Tablets USP 50 mg, distributed by Aurobindo Pharma USA, Inc. and relabeled by Enovachem Pharmaceuticals. The label includes the NDC 76420-498-09, quantity of 9 tablets, and a description of the tablets as white to off-white with capsule shape and biconvex/debossed design. Storage instructions and federal caution statements are also present.*

FDA Label Image

Package Label-principal Display Panel (Sumatriptan Fig5)

Sumatriptan Tablets USP 100 mg label showing package and product details. The label indicates the product is relabeled by Enovachem Pharmaceuticals and distributed by Aurobindo Pharma USA, Inc. It includes NDC 76420-500-09, quantity of 9 tablets, and cautions regarding storage and prescription requirements.*

FDA Label Image

Chemical Structure (Sumatriptan Str)

Chemical structure of Sumatriptan Succinate showing the molecular framework including indole moiety, sulfonamide group, and succinate salt components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.